Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

See How to

Filter conferences

 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
 
      
      
 
      
 
      
      
      
      
      
      
      
      
      
      
ADMET

ADMET

Categories

Date of beginning

Monday, 09 July 2018

Duration

2 days

Deadline for abstracts

-

City

London

Country

United Kingdom

Contact

02078276000

E-Mail

This email address is being protected from spambots. You need JavaScript enabled to view it.

Expected participants

0

Participants

0

Memo

Chaired by Eric Bloome, Vice President, Global Pre-Clinical Safety Senior Research Fellow, AbbVie



Developments in ADMET and novel technologies determine the properties of a drug candidate in the preclinical stage of drug discovery. Poor ADMET properties are the principal cause for a candidate to fail at any stage of drug development. ADME-Toxicology and Pharmacokinetic studies are the key strategic check-points for pharmaceutical companies to reduce drug discovery cost, and minimise production times.

The growing use of ADMET technologies is driving the market growth, which is estimated to reach $14,319.9 Million by 2022, with a CAGR of 10.6% from 2016 to 2022*. The main objective of early prediction of ADME properties of a compound is to increase the success rate of it reaching the development stage.

*Source: http://bit.ly/2hMJcgU



Join our expert speaker panels at the ADMET conference to ensure you do not miss out on the latest developments!

Presenting new technologies, specific case studies and PK modelling strategies in the areas of DMPK, PBPK, PKPD, in vitro / ex vivo / in vivo / in silico, biologics, transporters, hazard and safety assessments, ADMET modelling, and many more.



This event is CPD accredited.



The ADMET conference will cover new developments in all areas of the ADMET sector, from the evaluation of novel PBPK modelling techniques to the validation of humanised mice models.



Join us this year in July to hear from our expert speaker panel, bringing you interesting case studies and detailed presentations on new and industry relevant topics, including:

ADME/PK Optimisation for Drug Design and Discovery

Physiochemical Assessments

Drug Screening Technology

In Vitro to Human In Vivo Translation

DMPK, PBPK and PKPD Modelling

Pre-/Clinical Toxicity

Biopharmaceuticals

Accurate First-in-Human Dose Predictions

Transporters, Bioavailability, Formulation

Metabolism Studies

Drug-Drug Interactions



URLs:

Brochure: https://go.evvnt.com/207470-1?pid=5569

Booking : https://go.evvnt.com/207470-2?pid=5569



Prices:

Conference Only: GBP 1499,

Distribution of your company's promotional literature to all conference attendees: GBP 999,

Access to the conference documentation on the Document Portal: GBP 499,

The Conference Presentations - paper copy: GBP 499.



Venue details: Holiday Inn Kensington Forum, 97 Cromwell Rd Kensington, London, SW7 4DN, United Kingdom.



Speakers: Eric Bloome, Pau Aceves, Peter Littlewood, Filipe Lopes, Andreas Reichel, Laurent Salphati, Timothy Schulz-Utermoehl, Kunal Taskar, Robert Van Waterschoot, Ian Wilson.



Date and time: On Monday July 09, 2018 at 8:30 am and ends Tuesday July 10, 2018 at 4:30 pm